Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
		
    Effects of underfeeding and oral vancomycin on gut microbiome and nutrient absorption in humans.
        
        Nat. Med. 26, 589–598 (2020)
    
    
				Direct evidence in humans for the impact of the microbiome on nutrient absorption is lacking. We conducted an extended inpatient study using two interventions that we hypothesized would alter the gut microbiome and nutrient absorption. In each, stool calorie loss, a direct proxy of nutrient absorption, was measured. The first phase was a randomized cross-over dietary intervention in which all participants underwent in random order 3 d of over- and underfeeding. The second was a randomized, double-blind, placebo-controlled pharmacologic intervention using oral vancomycin or matching placebo (NCT02037295). Twenty-seven volunteers (17 men and 10 women, age 35.1 ± 7.3, BMI 32.3 ± 8.0), who were healthy other than having impaired glucose tolerance and obesity, were enrolled and 25 completed the entire trial. The primary endpoints were the effects of dietary and pharmacological intervention on stool calorie loss. We hypothesized that stool calories expressed as percentage of caloric intake would increase with underfeeding compared with overfeeding and increase during oral vancomycin treatment. Both primary endpoints were met. Greater stool calorie loss was observed during underfeeding relative to overfeeding and during vancomycin treatment compared with placebo. Key secondary endpoints were to evaluate the changes in gut microbial community structure as evidenced by amplicon sequencing and metagenomics. We observed only a modest perturbation of gut microbial community structure with under- versus overfeeding but a more widespread change in community structure with reduced diversity with oral vancomycin. Increase in Akkermansia muciniphila was common to both interventions that resulted in greater stool calorie loss. These results indicate that nutrient absorption is sensitive to environmental perturbations and support the translational relevance of preclinical models demonstrating a possible causal role for the gut microbiome in dietary energy harvest.
			
			
		Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Times Cited
Scopus
Cited By
					
					Cited By
Altmetric
					
				36.130
					5.856
					21
					28
					
					
				Anmerkungen
				
					
						 
						
					
				
			
				
			
				Besondere Publikation
				
					
						 
					
				
			
			
			
				Auf Hompepage verbergern
				
					
						 
					
				
			
			
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
     
    
    
        Schlagwörter
        Akkermansia-muciniphila; Energy-balance; Permeability; Metabolism; Accuracy; Obesity; Determinants; Antibiotics; Butyrate; Leptin
    
 
     
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2020
    
 
     
    
        HGF-Berichtsjahr
        2020
    
 
    
    
        ISSN (print) / ISBN
        1078-8956
    
 
    
        e-ISSN
        1546-170X
    
 
     
     
     
	     
	 
	 
    
        Zeitschrift
        Nature medicine
    
 
		
    
        Quellenangaben
        
	    Band: 26,  
	    Heft: 4,  
	    Seiten: 589–598 
	    
	    
	
    
 
  
         
        
            Verlag
            Nature Publishing Group
        
 
        
            Verlagsort
            New York, NY
        
 
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Begutachtungsstatus
        Peer reviewed
    
 
    
        Institut(e)
        Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
    
 
    
        POF Topic(s)
        30201 - Metabolic Health
    
 
    
        Forschungsfeld(er)
        Helmholtz Diabetes Center
    
 
    
        PSP-Element(e)
        G-506500-001
    
 
    
        Förderungen
        A*STAR
Searle Scholars Program
Damon Runyon Cancer Research Foundation
Burroughs Wellcome Fund
National Institutes of Health
Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
 
     	
    
    Searle Scholars Program
Damon Runyon Cancer Research Foundation
Burroughs Wellcome Fund
National Institutes of Health
Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
        WOS ID
        WOS:000618061900035
    
    
        WOS ID
        WOS:000521529700003
    
    
        Scopus ID
        85083389952
    
    
        PubMed ID
        32235930
    
    
        Erfassungsdatum
        2020-04-15